{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:34:17Z","timestamp":1792089257256,"version":"4.4.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100009867","name":"Emilia-Romagna Regional Healthcare Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009867","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.jhep.2023.06.017","type":"journal-article","created":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T21:08:23Z","timestamp":1689973703000},"page":"977-988","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["5-MTHF enhances the portal pressure reduction achieved with propranolol in patients with cirrhosis: A randomized placebo-controlled trial"],"prefix":"10.1016","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6062-4796","authenticated-orcid":false,"given":"Ranka","family":"Vukotic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Di Donato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5717-0591","authenticated-orcid":false,"given":"Greta","family":"Roncarati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8581-3585","authenticated-orcid":false,"given":"Patrizia","family":"Simoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1311-5670","authenticated-orcid":false,"given":"Matteo","family":"Renzulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8042-6508","authenticated-orcid":false,"given":"Stefano","family":"Gitto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6549-5102","authenticated-orcid":false,"given":"Filippo","family":"Schepis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6388-7022","authenticated-orcid":false,"given":"Erica","family":"Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4562-9016","authenticated-orcid":false,"given":"Annalisa","family":"Berzigotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaume","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4794-9809","authenticated-orcid":false,"given":"Pietro","family":"Andreone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2023.06.017_bib1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies","volume":"44","author":"D'Amico","year":"2006","journal-title":"J\u00a0Hepatol"},{"issue":"1 Suppl","key":"10.1016\/j.jhep.2023.06.017_bib2","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1016\/j.jhep.2015.01.003","article-title":"Evolution in the understanding of the pathophysiological basis of portal hypertension: how changes in paradigm are leading to successful new treatments","volume":"62","author":"Bosch","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.06.017_bib3","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/hep.22166","article-title":"Increased oxidative stress in cirrhotic rat livers: a potential mechanism contributing to reduced nitric oxide bioavailability","volume":"47","author":"Gracia-Sancho","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.06.017_bib4","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII - renewing consensus in portal hypertension","volume":"76","author":"De Franchis","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.06.017_bib5","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/S0140-6736(18)31875-0","article-title":"\u03b2 blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial","volume":"393","author":"Villanueva","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2023.06.017_bib6","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1053\/j.gastro.2006.09.013","article-title":"Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review","volume":"131","author":"D'Amico","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2023.06.017_bib7","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0016-5085(98)70372-5","article-title":"Propranolol plus prazosin compared with propranolol plus isosorbide-5-mononitrate in the treatment of portal hypertension","volume":"115","author":"Albillos","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2023.06.017_bib8","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1053\/jhep.2003.50053","article-title":"Low doses of isosorbide mononitrate attenuate the postprandial increase in portal pressure in patients with cirrhosis","volume":"37","author":"Bellis","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.06.017_bib9","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/ajg.2009.661","article-title":"NCX-1000, a nitric oxide-releasing derivative of UDCA, does not decrease portal pressure in patients with cirrhosis: results of a randomized, double-blind, dose-escalating study","volume":"105","author":"Berzigotti","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2023.06.017_bib10","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jhep.2008.04.014","article-title":"Three-day tetrahydrobiopterin therapy increases in\u00a0vivo hepatic NOS activity and reduces portal pressure in CCl4 cirrhotic rats","volume":"49","author":"Matei","year":"2008","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.06.017_bib11","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1161\/01.ATV.0000110785.96039.f6","article-title":"Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease","volume":"24","author":"Alp","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jhep.2023.06.017_bib12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1042\/CS20070108","article-title":"Mechanisms for the role of tetrahydrobiopterin in endothelial function and vascular disease","volume":"113","author":"Schmidt","year":"2007","journal-title":"Clin Sci"},{"key":"10.1016\/j.jhep.2023.06.017_bib13","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1161\/hc4601.098514","article-title":"Homocysteine impairs the nitric oxide synthase pathway. Role of asymmetric dimethylarginine","volume":"104","author":"St\u00fchlinger","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jhep.2023.06.017_bib14","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1136\/bmj.316.7135.894","article-title":"Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomized trials","volume":"316","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.jhep.2023.06.017_bib15","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0140-6736(99)07391-2","article-title":"Effect of homocysteine lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomized, placebo-controlled trial","volume":"355","author":"Vermeulen","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2023.06.017_bib16","doi-asserted-by":"crossref","first-page":"H816","DOI":"10.1152\/ajpheart.01348.2007","article-title":"Tissue-specific downregulation of dimethylarginine dimethylaminohydrolase in hyperhomocysteinemia","volume":"295","author":"Dayal","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jhep.2023.06.017_bib17","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jhep.2014.08.024","article-title":"Hepatic dimethylarginine-dimethylaminohydrolase1 is reduced in cirrhosis and is a target for therapy in portal hypertension","volume":"62","author":"Mookerjee","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.06.017_bib18","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/hep.20062","article-title":"The hepatic venous pressure gradient. Anything worth doing should be done right","volume":"39","author":"Groszmann","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.06.017_bib19","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/hep.21000","article-title":"Influence of beta-2 adrenergic receptor gene polymorphism on the hemodynamic response to propranolol in patients with cirrhosis","volume":"43","author":"Turnes","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.06.017_bib20","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/hep.1840050314","article-title":"The effect of the combination of nitroglycerin and propranolol on splanchnic and systemic hemodynamics in a portal hypertensive rat model","volume":"5","author":"Kroeger","year":"1985","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.06.017_bib21","doi-asserted-by":"crossref","DOI":"10.1053\/jhep.2003.50211","article-title":"Propranolol plus placebo versus propranolol plus isosorbide-5-mononitrate in the prevention of a first variceal bleed: a double-blind RCT","volume":"37","author":"Garc\u00eda-Pag\u00e1n","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.06.017_bib22","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/hep.21080","article-title":"Ascorbic acid improves the intrahepatic endothelial dysfunction of patients with cirrhosis and portal hypertension","volume":"43","author":"Hern\u00e1ndez-Guerra","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.06.017_bib23","doi-asserted-by":"crossref","first-page":"584","DOI":"10.3945\/ajcn.112.040469","article-title":"Postprandial effects of dark chocolate on portal hypertension in patients with cirrhosis: results of a phase 2, double-blind, randomized controlled trial","volume":"96","author":"De Gottardi","year":"2012","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jhep.2023.06.017_bib24","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1136\/gutjnl-2019-318237","article-title":"Cirrhosis as new indication for statins","volume":"69","author":"Bosch","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2023.06.017_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910372","article-title":"Cyclic GMP in liver cirrhosis-role in pathophysiology of portal hypertension and therapeutic implications","volume":"22","author":"Kreisel","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jhep.2023.06.017_bib26","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1055\/s-0037-1614070","article-title":"Contribution of the cystathionine beta-synthase gene (844ins68) polymorphism to the risk of early -onset venous and arterial disease and fasting hyperhomocysteinemia","volume":"84","author":"De Franchis","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jhep.2023.06.017_bib27","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.aohep.2018.12.008","article-title":"Folic acid ameliorates homocysteine-induced angiogenesis and portosystemic collaterals in cirrhotic rats","volume":"18","author":"Ho","year":"2019","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jhep.2023.06.017_bib28","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrgastro.2009.149","article-title":"The clinical use of HVPG measurements in chronic liver disease","volume":"6","author":"Bosch","year":"2009","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2023.06.017_bib29","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1053\/jhep.2000.19322","article-title":"The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis","volume":"32","author":"Merkel","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.06.017_bib30","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1136\/gutjnl-2014-308338","article-title":"KLF2 exerts antifibrotic and vasoprotective effects in cirrhotic rat livers: behind the molecular mechanisms of statins","volume":"64","author":"Marrone","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2023.06.017_bib31","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jhep.2012.08.026","article-title":"The transcription factor KLF2 mediates hepatic endothelial protection and paracrine endothelial-stellate cell deactivation induced by statins","author":"Marrone","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.06.017_bib32","article-title":"Nuclear deformation mediates liver cell mechanosensing in cirrhosis","volume":"2","author":"Guix\u00e9-Muntet","year":"2020","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhep.2023.06.017_bib33","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1016\/j.cgh.2021.10.023","article-title":"Decompensation in advanced nonalcoholic fatty liver disease may occur at lower hepatic venous pressure gradient levels than in patients with viral disease","volume":"20","author":"Bassegoda","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2023.06.017_bib34","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jhep.2021.09.029","article-title":"Overlooked subclinical portal hypertension in non-cirrhotic NAFLD: is it real and how to measure it?","volume":"76","author":"Baffy","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.06.017_bib35","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/hep.510300628","article-title":"Wedged hepatic venous pressure adequately reflects portal\u00a0pressure in hepatitis C virus-related cirrhosis","volume":"30","author":"Perell\u00f3","year":"1999","journal-title":"Hepatology"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827823049401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827823049401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:50:08Z","timestamp":1759175408000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827823049401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S0168827823049401"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2023.06.017","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"5-MTHF enhances the portal pressure reduction achieved with propranolol in patients with cirrhosis: A randomized placebo-controlled trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2023.06.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}